1
I Use This!
Activity Not Available
Analyzed over 1 year ago. based on code collected over 1 year ago.

Project Summary

A widely used platform for multiple sequence alignment analysis built in Java.

Jalview has been developed since 1998, and its development is coordinated by the Barton group at the University Of Dundee, with support from the UK's Biotechnology and Biological Sciences Research Council, The Wellcome Trust, and contributions from students supported by The Google Summer Of Code.

Tags

bbsrc bioinformatics biology gsoc java multiplesequencealignment science sequenceanalysis visualisation visualization wellcome

GNU General Public License v3.0 only
Permitted

Commercial Use

Modify

Distribute

Place Warranty

Use Patent Claims

Forbidden

Sub-License

Hold Liable

Required

Distribute Original

Disclose Source

Include Copyright

State Changes

Include License

Include Install Instructions

These details are provided for information only. No information here is legal advice and should not be used as such.

Project Security

Vulnerabilities per Version ( last 10 releases )

There are no reported vulnerabilities

Project Vulnerability Report

Security Confidence Index

Poor security track-record
Favorable security track-record

Vulnerability Exposure Index

Many reported vulnerabilities
Few reported vulnerabilities

Did You Know...

  • ...
    nearly 1 in 3 companies have no process for identifying, tracking, or remediating known open source vulnerabilities
  • ...
    by exploring contributors within projects, you can view details on every commit they have made to that project
  • ...
    there are over 3,000 projects on the Open Hub with security vulnerabilities reported against them
  • ...
    search using multiple tags to find exactly what you need
About Project Security

Languages

Java
87%
XML
5%
HTML
5%
13 Other
3%

30 Day Summary

Jan 14 2024 — Feb 13 2024

12 Month Summary

Feb 13 2023 — Feb 13 2024
  • 900 Commits
    Up + 376 (71%) from previous 12 months
  • 3 Contributors
    Down -2 (40%) from previous 12 months